Patents for C12R 1 - Micro-organisms (92,025)
05/1991
05/29/1991EP0429209A1 New antibiotic chemical compound "DC 114-C"
05/29/1991EP0429093A2 Transformation of plant genotype
05/29/1991EP0428615A1 Method for stabilizing heterologous protein expression and vectors for use therein
05/29/1991EP0248832B1 Method for cultivating microorganisms, particularly of the frankia group and preparation of bacterial inoculums
05/29/1991EP0229161B1 Composite plasmids for amino acid synthesis
05/29/1991DE3938971A1 Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat Leukocyte elastase and cathepsin G-blocking peptide, dna, vector, host organism and proceed to its recovery as well as pharmaceutical of preparation
05/29/1991CN1051757A Polypeptide compound and process for preparation thereof
05/29/1991CA2030929A1 Bacterial collagenase gene
05/29/1991CA2030912A1 Dna-sequence conferring resistance to the antibiotic thermorubin
05/29/1991CA2029249A1 Method for the fermentative production of diacetyl and acetoin using lactic acid bacterium
05/28/1991WO1991008300A1 Process for the preparation of vancomycin
05/28/1991US5019648 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein
05/28/1991US5019593 Antifungal fermentation products and compositions thereof
05/28/1991US5019514 Aureobasidium pullulans strain, process for its preparation, and use thereof
05/28/1991US5019507 Novel cyclomaltodextrin glucanotransferase
05/28/1991US5019505 Enzymes having alpha-glycerol-3-phosphate oxidase activity, production and use thereof
05/28/1991US5019503 Method for production of l-threonine
05/28/1991US5019501 Process for the activation of promoters of bacteria
05/28/1991US5019500 IGF-I fusion proteins; protection of IGF-I from degradation by host cell proteases; and processes for the production thereof
05/28/1991US5019499 Method of producing peptides by transforming myeloma cells with a recombinant plasmid
05/28/1991CA2045483A1 Process for the preparation of vancomycin
05/28/1991CA2030927A1 Fibrinolytic protein and production method thereof
05/28/1991CA1284464C D(-)-mandelate dehydrogenase produced microbiologically, a process for its production and application thereof
05/23/1991DE4007043A1 New restriction endonuclease RleAi from Rhizobium - recognising and cutting specific base sequence, useful in DNA analysis
05/22/1991EP0428485A1 Novel antiidiotypic monoclonal antibodies
05/22/1991EP0428286A2 24- and 25-substituted avermectin and milbemycin derivatives
05/22/1991EP0428267A2 Erythropoietin isoforms
05/22/1991EP0428141A2 Hybrid promoter
05/22/1991EP0428061A1 Type II restriction endonuclease McrI
05/22/1991EP0428060A1 Type II restriction endonuclease RleAI
05/22/1991EP0427806A1 Fat hydrolysis process.
05/22/1991EP0427771A1 Macrolactam antimicrobial compounds
05/22/1991EP0237545B1 Production of pluripotent granulocyte colony-stimulating factor
05/22/1991CN1051600A Dye transfer inhibition
05/21/1991WO1991007425A1 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens
05/21/1991US5017603 Xanthomegnin, a known compound, is an antiparasitic agent
05/21/1991US5017495 Biosynthesis of p-cresol
05/21/1991US5017493 Ribosmoe binding site
05/21/1991US5017487 Genetic engineering
05/21/1991US5017482 Process for producing L-arginine
05/21/1991US5017481 Biosynthesis
05/21/1991US5017479 Enzymatic hydrolysis
05/21/1991US5017388 Process for the preparation of vanillin
05/21/1991CA2068713A1 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens
05/18/1991WO1991007500A1 Specific binding agents
05/18/1991WO1991007490A1 Protein complexes having factor viii:c activity and production thereof
05/18/1991WO1991007481A1 Mutants or variants of bacillus thuringiensis producing high yields of delta endotoxin
05/18/1991CA2135744A1 Protein complexes having factor viii:c activity and production thereof
05/18/1991CA2068728A1 Protein complexes having factor viii:c activity and production thereof
05/18/1991CA2066670A1 Specific binding agents
05/16/1991WO1991006866A2 Urinary tumor associated antigen, antigenic subunits uses and methods of detection
05/16/1991WO1991006861A1 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products
05/16/1991WO1991006667A1 Production of proteins using homologous recombination
05/16/1991WO1991006666A1 Production of proteins using homologous recombination
05/16/1991WO1991006663A1 Process for preparing ganglioside g¿m1?
05/16/1991WO1991006662A1 Process for preparing asialo g¿m1?
05/16/1991WO1991006660A1 Site-specific modification of the candida tropicalis genome
05/16/1991WO1991006658A2 Infective protein delivery system
05/16/1991WO1991006656A1 Promoter, expression vector and polypeptide synthesis
05/16/1991WO1991006655A1 E. coli secretory strains
05/16/1991WO1991006654A1 A method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
05/16/1991WO1991006653A1 Recombinant vaccine for porcine pleuropneumonia
05/16/1991WO1991006648A1 Glutamate receptor compositions and methods
05/16/1991WO1991006632A1 Inhibition of padgem-mediated cell binding
05/16/1991WO1991006574A1 A process for preparing peroxycarboxylic acids
05/16/1991WO1991006571A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor
05/16/1991WO1991006568A1 High molecular weight human angiogenic factors
05/16/1991WO1991006566A1 Novel compounds
05/16/1991WO1991006552A1 A83543 recovery process
05/16/1991WO1991006319A1 Methods and compositions for promoting immunopotentiation
05/16/1991WO1990013634A3 Enzymes and their use in drug detection
05/16/1991WO1990012879A3 Expression of human apolipoproteins ai-milano in yeast
05/16/1991CA2072977A1 Site-specific modification of the candida tropicalis genome
05/16/1991CA2072657A1 Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
05/16/1991CA2071478A1 Methods and compositions for promoting immunopotentiation
05/15/1991EP0427680A1 Heteroatoms-containing tricyclic compounds
05/15/1991EP0427462A1 Process
05/15/1991EP0427405A1 Yeasts and their use in astaxanthin production
05/15/1991EP0427399A1 Cancer marker and monoclonal antibodies specific therefor
05/15/1991EP0427385A1 Gene expression unit comprising the promoter and the terminator as well as the gene of alkaline protease
05/15/1991EP0427296A1 Insulin precursors
05/15/1991EP0427189A1 Modified forms of human erythropoietin and DNA sequences encoding genes which can express them
05/15/1991EP0427142A1 Antibiotic A/16686 recovery process
05/15/1991EP0427035A1 Protein overexpression in recombinant host cells
05/15/1991EP0427014A1 Plasmid
05/15/1991EP0426787A1 POLYPEPTIDE RESULTING FROM THE FUSION BETWEEN A MALTOSE-RELATED COMPOUND (MalE) AND A CD4 FRAGMENT FOR NEUTRALIZING THE AIDS VIRUS
05/15/1991EP0426744A1 High efficiency translation of polycistronic messages in eucaryotic cells
05/15/1991CN1051393A Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
05/15/1991CN1051389A Novel antibodies reactive with human carcinomas
05/15/1991CN1051302A Biologically active proteins and method for their prodn.
05/15/1991CA2029714A1 Antiidiotypic monoclonal antibodies
05/14/1991WO1991007664A1 Diagnostic proteins to test for more than one antibody
05/14/1991WO1991007494A1 Chimeric mouse human antibodies with specificity to hiv antigens
05/14/1991WO1991007482A1 Type-b rotavirus cultures and uses thereof
05/14/1991WO1991007418A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
05/14/1991US5015662 Anthelmintic bioconversion products
05/14/1991US5015581 Method for producing the Hinc II restriction endonuclease and methylase
05/14/1991US5015579 Production of (-)trans-2,3-epoxysuccinic acid by fermentation
05/14/1991US5015578 BMY-41950 antitumor antibiotic
05/14/1991US5015574 Genetic engineering